These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 28539171)
21. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis. Zhang ZJ; Li S Diabetes Obes Metab; 2014 Aug; 16(8):707-10. PubMed ID: 24460896 [TBL] [Abstract][Full Text] [Related]
22. Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis. Chu D; Wu J; Wang K; Zhao M; Wang C; Li L; Guo R BMC Cancer; 2018 Apr; 18(1):438. PubMed ID: 29669520 [TBL] [Abstract][Full Text] [Related]
23. The effect of metformin on mortality following cancer among patients with diabetes. Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683 [TBL] [Abstract][Full Text] [Related]
24. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study. Mamza J; Mehta R; Donnelly R; Idris I Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210 [TBL] [Abstract][Full Text] [Related]
25. Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes. Urpilainen E; Arima R; Karihtala P; Puistola U; Ahtikoski A Anticancer Res; 2021 Feb; 41(2):821-828. PubMed ID: 33517287 [TBL] [Abstract][Full Text] [Related]
26. Metformin use and endometrial cancer survival. Nevadunsky NS; Van Arsdale A; Strickler HD; Moadel A; Kaur G; Frimer M; Conroy E; Goldberg GL; Einstein MH Gynecol Oncol; 2014 Jan; 132(1):236-40. PubMed ID: 24189334 [TBL] [Abstract][Full Text] [Related]
27. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis. Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955 [TBL] [Abstract][Full Text] [Related]
28. Effects of metformin on endometrial cancer: Systematic review and meta-analysis. Meireles CG; Pereira SA; Valadares LP; Rêgo DF; Simeoni LA; Guerra ENS; Lofrano-Porto A Gynecol Oncol; 2017 Oct; 147(1):167-180. PubMed ID: 28760367 [TBL] [Abstract][Full Text] [Related]
29. Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis. Raval AD; Thakker D; Vyas A; Salkini M; Madhavan S; Sambamoorthi U Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):110-21. PubMed ID: 25667109 [TBL] [Abstract][Full Text] [Related]
30. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan. Tseng CH Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129 [TBL] [Abstract][Full Text] [Related]
31. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis. Yin M; Zhou J; Gorak EJ; Quddus F Oncologist; 2013; 18(12):1248-55. PubMed ID: 24258613 [TBL] [Abstract][Full Text] [Related]
32. Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis. Xin WX; Fang L; Fang QL; Zheng XW; Ding HY; Huang P Medicine (Baltimore); 2018 Mar; 97(9):e0035. PubMed ID: 29489653 [TBL] [Abstract][Full Text] [Related]
33. The influence of metformin and the presence of type 2 diabetes mellitus on mortality and hospitalisation in patients with heart failure. Retwiński A; Kosmalski M; Crespo-Leiro M; Maggioni A; Opolski G; Ponikowski P; Poloński L; Jankowska E; Drzewoski J; Drożdż J Kardiol Pol; 2018; 76(9):1336-1343. PubMed ID: 29862487 [TBL] [Abstract][Full Text] [Related]
34. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies. Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783 [TBL] [Abstract][Full Text] [Related]
35. New therapeutic approaches for the fertility-sparing treatment of endometrial cancer. Mitsuhashi A; Shozu M J Obstet Gynaecol Res; 2020 Feb; 46(2):215-222. PubMed ID: 32017321 [TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C. Harris K; Smith L Ann Pharmacother; 2013 Oct; 47(10):1348-52. PubMed ID: 24259699 [TBL] [Abstract][Full Text] [Related]
37. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients. Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892 [TBL] [Abstract][Full Text] [Related]
38. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis. Meng F; Song L; Wang W J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076 [No Abstract] [Full Text] [Related]
39. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts. Al Hilli MM; Bakkum-Gamez JN; Mariani A; Cliby WA; Mc Gree ME; Weaver AL; Dowdy SC; Podratz KC Gynecol Oncol; 2016 Feb; 140(2):270-6. PubMed ID: 26607780 [TBL] [Abstract][Full Text] [Related]
40. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes. Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]